Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Kohanbash

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Journal of Biomedical Optics|September 23, 2024
Detection properties of indium-111 and IRDye800CW for intraoperative molecular imaging use across tissue phantom modelsReidAnn E Sever, Lauren T Rosenblum, Kayla C Stanley, et al.
Cancer Immunology, Immunotherapy : CII|June 16, 2010
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent mannersXinmei Zhu, Beth A Fallert-Junecko, Mitsugu Fujita, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Quantitative Sodium (<sup>23</sup>Na) MRI in Pediatric Gliomas: Initial ExperienceAashim Bhatia, Vincent Kyu Lee, Yongxian Qian, et al.
Current Issues in Molecular Biology|September 17, 2020
Oncolytic HSV Vectors and Anti-Tumor ImmunityJoseph C Glorioso, Justus B Cohen, William F Goins, et al.
Neuro-Oncology|February 14, 2025
Immuno-epidemiologic mapping of HLA diversity across glioma patient cohortsZujian Xiong, Kyle M Walsh, Chaim T Sneiderman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumorsKotaro Sasaki, Angela D Pardee, Yanyan Qu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2009
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1Ryo Ueda, Gary Kohanbash, Kotaro Sasaki, et al.
Theranostics|January 4, 2021
Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cellsMd Nabiul Hasan, Lanxin Luo, Dawei Ding, et al.
Neuro-Oncology|April 28, 2016
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expressionXiaoran Zhang, Aparana Rao, Paola Sette, et al.
Molecular Cancer Therapeutics|May 13, 2020
Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces AstrogliosisLanxin Luo, Xiudong Guan, Gulnaz Begum, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Journal of Biomedical Optics|September 23, 2024
Detection properties of indium-111 and IRDye800CW for intraoperative molecular imaging use across tissue phantom modelsReidAnn E Sever, Lauren T Rosenblum, Kayla C Stanley, et al.
Cancer Immunology, Immunotherapy : CII|June 16, 2010
Poly-ICLC promotes the infiltration of effector T cells into intracranial gliomas via induction of CXCL10 in IFN-alpha and IFN-gamma dependent mannersXinmei Zhu, Beth A Fallert-Junecko, Mitsugu Fujita, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Quantitative Sodium (<sup>23</sup>Na) MRI in Pediatric Gliomas: Initial ExperienceAashim Bhatia, Vincent Kyu Lee, Yongxian Qian, et al.
Current Issues in Molecular Biology|September 17, 2020
Oncolytic HSV Vectors and Anti-Tumor ImmunityJoseph C Glorioso, Justus B Cohen, William F Goins, et al.
Neuro-Oncology|February 14, 2025
Immuno-epidemiologic mapping of HLA diversity across glioma patient cohortsZujian Xiong, Kyle M Walsh, Chaim T Sneiderman, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
IL-4 suppresses very late antigen-4 expression which is required for therapeutic Th1 T-cell trafficking into tumorsKotaro Sasaki, Angela D Pardee, Yanyan Qu, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2009
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1Ryo Ueda, Gary Kohanbash, Kotaro Sasaki, et al.
Theranostics|January 4, 2021
Blocking NHE1 stimulates glioma tumor immunity by restoring OXPHOS function of myeloid cellsMd Nabiul Hasan, Lanxin Luo, Dawei Ding, et al.
Neuro-Oncology|April 28, 2016
IDH mutant gliomas escape natural killer cell immune surveillance by downregulation of NKG2D ligand expressionXiaoran Zhang, Aparana Rao, Paola Sette, et al.
Molecular Cancer Therapeutics|May 13, 2020
Blockade of Cell Volume Regulatory Protein NKCC1 Increases TMZ-Induced Glioma Apoptosis and Reduces AstrogliosisLanxin Luo, Xiudong Guan, Gulnaz Begum, et al.
Pageof 9